Ji Hyae Lee

Ji Hyae Lee

Auto-generated profile, based on publicly available information

Ji Hyae Lee

Department of Chemistry Seoul National University Seoul South Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2023 in Communications Chemistry
Verified
Journal Article
Open access
PDF file
KVKannan Vaithegi
Kannan Vaithegi
SYSihyeong Yi
Sihyeong Yi
JLJi Hyae Lee
Ji Hyae Lee
BVBegur Vasanthkumar Varun
Begur Vasanthkumar Varun
Seung Bum ParkSeung Bum Park
Seung Bum Park
Substituted pyridines with diverse functional groups are important structural motifs found in numerous bioactive molecules. Several methodologies for the introduction of various bio-relevant functional groups to pyridine have been reported, but there is still a need for a single robust method allowing the selective introduction of multiple functional groups. This study reports a ring cleavage methodology reaction for the synthesis of 2-alkyl/aryl 3-electron-withdrawing groups (esters, sulfones, and phosphonates) 5-aminoaryl/phenol pyridines via the remodeling of 3-formyl (aza)indoles/benzofurans. Totally ninety-three 5-aminoaryl pyridines and thirty-three 5-phenol pyridines were synthesized showing the robustness of the developed methodology. The application of this methodology further provided a privileged pyridine scaffold containing biologically relevant molecules and direct drug/natural product conjugation with ethyl 2-methyl nicotinate.

28 June 2024 in Communications Chemistry
Verified
Journal Article
Open access
PDF file
SYSihyeong Yi
Sihyeong Yi
JLJi Hyae Lee
Ji Hyae Lee
HCHana Cho
Hana Cho
KVKannan Vaithegi
Kannan Vaithegi
DYDawon Yi
Dawon Yi
Seung Bum ParkSeung Bum Park
Seung Bum Park
Pyridine, an essential structure in drug development, shows a wide array of bioactivities according to its substitution patterns. Among the bioactive pyridines, meta-substituted pyridines suffer from limited synthetic approaches despite their significance. In this study, we present a condensation-based synthetic method enabling the facile incorporation of biologically relevant functional groups at the meta position of pyridine. This methodology unveiled the concealed reactivity of 3-formyl(aza)indoles as diformylmethane analogs for synthesizing dissymmetric di-meta-substituted pyridines without ortho and para substitutions. Furthermore, we uncovered resonance-assisted hydrogen bonding (RAHB) as the requirement for the in situ generation of enamines, the key intermediates of this transformation. Successful development of the designed methodology linked to wide applications—core remodeling of natural products, drug–natural product conjugation, late-stage functionalization of drug molecules, and synthesis of the regioisomeric CZC24832. Furthermore, we discovered anti-inflammatory agents through the functional evaluation of synthesized bi-heteroaryl analogs, signifying the utility of this methodology.

9 October 2025 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
JLJi Hyae Lee
Ji Hyae Lee
SYSihyeong Yi
Sihyeong Yi
JBJuhyun Bang
Juhyun Bang
HCHyun Choi
Hyun Choi
Seung Bum ParkSeung Bum Park
Seung Bum Park
Macrocycles represent a promising class of drug‐like scaffolds with unique structural features and the ability to engage challenging targets such as protein–protein interactions. Inspired by structural characteristics of pyritides, we constructed a library of 27 diverse macrocycles via a build/couple/pair approach, enabled by efficient synthesis of bipyridine‐based triaryl building blocks through azaindole cleavage. Kinetic and cheminformatic analyses confirmed both reactivity trends and structural diversity. From this library, we identified a potential ferroptosis inhibitor, 6 p aW , with clear structure–activity relationships, validating our diversity‐oriented synthesis platform. This strategy offers a robust approach to macrocycle library design, expanding opportunities for targeting previously inaccessible biological space.

9 October 2025 in Angewandte Chemie
Verified
Journal Article
Open access
JLJi Hyae Lee
Ji Hyae Lee
SYSihyeong Yi
Sihyeong Yi
JBJuhyun Bang
Juhyun Bang
HCHyun Choi
Hyun Choi
Seung Bum ParkSeung Bum Park
Seung Bum Park
Macrocycles represent a promising class of drug‐like scaffolds with unique structural features and the ability to engage challenging targets such as protein–protein interactions. Inspired by structural characteristics of pyritides, we constructed a library of 27 diverse macrocycles via a build/couple/pair approach, enabled by efficient synthesis of bipyridine‐based triaryl building blocks through azaindole cleavage. Kinetic and cheminformatic analyses confirmed both reactivity trends and structural diversity. From this library, we identified a potential ferroptosis inhibitor, 6 p aW , with clear structure–activity relationships, validating our diversity‐oriented synthesis platform. This strategy offers a robust approach to macrocycle library design, expanding opportunities for targeting previously inaccessible biological space.

10 August 2026 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
JLJesang Lee
Jesang Lee
SSSumin Son
Sumin Son
JYJeong Yeon Yoo
Jeong Yeon Yoo
JLJi Hyae Lee
Ji Hyae Lee
MCMeehyun Chun
Meehyun Chun
Seung Bum ParkSeung Bum Park
Seung Bum Park
Peptidomimetics have matured from motif‑based inhibitors into a structural engineering discipline that systematically translates peptide recognition surfaces into drug‑like scaffolds. Driven by the urgent clinical demand to overcome the inherent pharmacological liabilities of biomolecules, the field is undergoing a decisive Peptide‐to‐Small Molecule paradigm shift—functionally converting peptide‐derived recognition motifs into orally bioavailable synthetic therapeutics. This Perspective highlights how foundational geometric design principles—linear repetition, convergent fusion, and cyclization—define next‑generation architectures capable of targeting complex protein–protein interactions (PPIs). Repeating‑unit oligomers exemplify linear projection strategies, heterocycle‑centered scaffolds embody the convergent fusion of recognition motifs, and macrocyclic frameworks pre‐organize bioactive conformations while enabling access to non‑canonical topologies. Beyond simple mimicry, these architectures increasingly embrace dynamic responsiveness, aggregation remodeling, and universal multi‑structure platforms. We argue that the convergence of geometric logic with automated synthesis and AI‑driven design will transform peptidomimetics into a primary modality for decoding and therapeutically engaging the human interactome, including historically “undruggable” PPIs.

11 August 2026 in Angewandte Chemie
Verified
Journal Article
Open access
JLJesang Lee
Jesang Lee
SSSumin Son
Sumin Son
JYJeong Yeon Yoo
Jeong Yeon Yoo
JLJi Hyae Lee
Ji Hyae Lee
MCMeehyun Chun
Meehyun Chun
Seung Bum ParkSeung Bum Park
Seung Bum Park
Peptidomimetics have matured from motif‑based inhibitors into a structural engineering discipline that systematically translates peptide recognition surfaces into drug‑like scaffolds. Driven by the urgent clinical demand to overcome the inherent pharmacological liabilities of biomolecules, the field is undergoing a decisive Peptide‐to‐Small Molecule paradigm shift—functionally converting peptide‐derived recognition motifs into orally bioavailable synthetic therapeutics. This Perspective highlights how foundational geometric design principles—linear repetition, convergent fusion, and cyclization—define next‑generation architectures capable of targeting complex protein–protein interactions (PPIs). Repeating‑unit oligomers exemplify linear projection strategies, heterocycle‑centered scaffolds embody the convergent fusion of recognition motifs, and macrocyclic frameworks pre‐organize bioactive conformations while enabling access to non‑canonical topologies. Beyond simple mimicry, these architectures increasingly embrace dynamic responsiveness, aggregation remodeling, and universal multi‑structure platforms. We argue that the convergence of geometric logic with automated synthesis and AI‑driven design will transform peptidomimetics into a primary modality for decoding and therapeutically engaging the human interactome, including historically “undruggable” PPIs.